Endostart, a pioneering medical device company specializing in gastrointestinal endoscopy solutions, HAS announces a major breakthrough with the FDA 510(k) clearance of its flagship product, Endorail. This achievement represents a significant step forward in advancing the field of gastrointestinal endoscopy and improving patient care worldwide, according to a news release.
Now commercially available in the U.S., Endorail enhances the efficiency and safety of endoscopic procedures, offering a revolutionary solution to solve looping and facilitate the completion of prolonged colonoscopies. Designed to streamline the colonoscopy process, Endorail combines its innovative magnetic balloon solution with user-friendly features, empowering physicians to overcome procedural challenges with confidence and precision.
Colonoscopy remains a cornerstone procedure for the diagnosis, surveillance, prevention and treatment of various colon diseases, including colorectal cancer and chronic inflammatory bowel diseases. With Endorail, physicians gain access to a powerful on-demand tool that not only optimizes procedural outcomes but also reduces the health care costs associated with prolonged or incomplete procedures.
“We are thrilled to obtain FDA clearance for Endorail, marking a significant milestone in our journey to revolutionize gastrointestinal endoscopy,” said Dr. Alessandro Tozzi, co-founder and CEO of Endostart. “This clearance underscores our commitment to innovation and our dedication to improving patient care. We look forward to introducing Endorail to endoscopic centers across the United States, empowering physicians with the tools they need to deliver exceptional care.”
In 2023, Endostart conducted a multicenter clinical trial to demonstrate the high safety and efficacy profile of Endorail in the completion of difficult colonoscopies. The results of this study will be presented at the Digestive Disease Week Congress, taking place in Washington, D.C., May 18-21, 2024.
“Through this study, Endostart and our research partners have established that Endorail is safe and can be used effectively on demand in patients with prolonged colonoscopies. Future studies will be carried out to identify additional benefits, including cost advantages and time-saving with our device,” added Tozzi.
